Management of Vasopressor-Resistant Septic Shock
When norepinephrine alone fails to achieve a MAP ≥65 mmHg despite adequate fluid resuscitation, add vasopressin at 0.03 units/minute to either raise MAP to target or decrease norepinephrine requirements. 1, 2
Stepwise Escalation Algorithm
First-Line: Optimize Norepinephrine
- Start norepinephrine as the first-choice vasopressor, targeting MAP ≥65 mmHg 1, 2
- Ensure adequate fluid resuscitation (minimum 30 mL/kg crystalloids) has been initiated, but do not delay vasopressors waiting for complete fluid resuscitation if life-threatening hypotension exists 1, 2, 3
- Place arterial catheter for continuous blood pressure monitoring as soon as practical 1, 2
- Titrate norepinephrine upward to achieve target MAP 1
Second-Line: Add Vasopressin
When norepinephrine requirements remain elevated or target MAP is not achieved:
- Add vasopressin at 0.03 units/minute (do NOT use as monotherapy) 1, 2, 4
- The FDA-approved starting dose for septic shock is 0.01 units/minute, titrated up by 0.005 units/minute at 10-15 minute intervals 4
- Maximum recommended dose is 0.03-0.04 units/minute; higher doses should be reserved for salvage therapy only 1, 2
- Vasopressin reaches peak pressor effect within 15 minutes 4
Third-Line: Add Epinephrine or Dobutamine
If hypotension persists despite norepinephrine plus vasopressin:
- Add epinephrine to norepinephrine and vasopressin when additional agent is needed to maintain adequate blood pressure 1
- Consider dobutamine (up to 20 μg/kg/min) if there is evidence of persistent hypoperfusion despite adequate fluid loading and vasopressor use, particularly with myocardial dysfunction (elevated cardiac filling pressures, low cardiac output) 1, 2
Salvage Therapy Considerations
For truly refractory shock:
- Phenylephrine is NOT recommended except in specific circumstances: (a) norepinephrine causes serious arrhythmias, (b) cardiac output is known to be high with persistently low blood pressure, or (c) as salvage therapy when combined inotrope/vasopressor drugs and low-dose vasopressin have failed 1, 2
- Consider hydrocortisone 200 mg/day if adequate fluid resuscitation and vasopressor therapy cannot restore hemodynamic stability 1
Critical Monitoring Requirements
Hemodynamic Monitoring
- Continuous arterial blood pressure monitoring via arterial catheter 1, 2
- Monitor markers of tissue perfusion beyond MAP: lactate clearance, urine output, mental status, skin perfusion 2, 5
- Assess for signs of excessive vasoconstriction: digital ischemia, decreased urine output, rising lactate, worsening organ dysfunction despite adequate MAP 2
Vasopressor Weaning
- After target blood pressure is maintained for 8 hours without catecholamines, taper vasopressin by 0.005 units/minute every hour as tolerated 4
- Taper hydrocortisone when vasopressors are no longer required 1
Agents to AVOID
Dopamine
- Do NOT use dopamine as first-line therapy—it is associated with higher mortality and more arrhythmias compared to norepinephrine 1, 2, 6, 7
- Use dopamine only in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia 1, 2
- Never use low-dose dopamine for renal protection—this is strongly discouraged with high-quality evidence showing no benefit 1, 2, 6
Other Contraindicated Approaches
- Do not use vasopressin as sole initial vasopressor 1, 2, 6
- Do not exceed vasopressin 0.03-0.04 units/minute except as salvage therapy 1, 2
- Avoid phenylephrine as routine therapy—it may raise blood pressure while actually worsening tissue perfusion through excessive vasoconstriction 1, 2
Common Pitfalls to Avoid
- Do not delay norepinephrine initiation waiting for complete fluid resuscitation if life-threatening hypotension exists 2, 3, 5
- Do not rely solely on MAP—monitor tissue perfusion markers (lactate, urine output, mental status) to guide therapy 2, 5
- Do not use vasopressin as monotherapy—it must always be added to norepinephrine, never used alone 1, 2, 6
- Do not escalate vasopressin beyond 0.03-0.04 units/minute—add epinephrine or dobutamine instead 1, 2
- Avoid excessive vasoconstriction—titrate to adequate perfusion markers, not supranormal blood pressure targets 2